May 5 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- REVIEWING & CONSIDERING INFORMATION CONTAINED IN HEALIUS TARGET’S STATEMENT WITH ITS ADVISERS
- ACL'S OFFER FOR HEALIUS IS OPEN FOR ACCEPTANCE UNTIL 7.00PM (SYDNEY TIME) ON 29 SEPT
- NOTES HEALIUS IDENTIFIES NUMBER OF CONDITIONS OF OFFER THAT IT CONSIDERS ARE NOT LIKELY TO BE SATISFIED
News: ACL Australian Clinical Labs Says Reviewing Healius' Target's Statement
Add ACL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.31 |
Change
0.060(2.67%) |
Mkt cap ! $462.2M | |||
| Open | High | Low | Value | Volume |
| $2.27 | $2.31 | $2.27 | $383.7K | 167.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 12827 | $2.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.31 | 30487 | 12 |
View Market Depth
| Last trade - 12.29pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.31 |
Change
0.060 ( 2.47 %) |
||||
| Open | High | Low | Volume | ||
| $2.28 | $2.31 | $2.27 | 24822 | ||
| Last updated 12.35pm 06/06/2024 ? | |||||
| ACL (ASX) Chart |